South Korea-based International Vaccine Institute (IVI), an international organisation with a mission to discover, devel...
South Korea-based GC Biopharma has signed a Memorandum of Understanding (MoU) with Eubiologics (also based in South Kore...
South Korea-based SK bioscience has entered into a collaboration agreement with Vaxxas, an Australian biotechnology comp...
MGI, a China-based company committed to building core tools and technology to lead life scienc,e and South Korea based s...
London-based Hikma Pharmaceuticals PLC has announced a new strategic partnership and exclusive licensing agreement...
Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as th...
South Korea-based startup Standigm, a company using artificial intelligence (AI) technology for drug discovery and devel...
The industry in Korea has seen its ‘growth potential’ increase by 7% in the 2023 CPHI Annual Survey. With th...
South Korea-based startup Kakao Healthcare has signed a business agreement with Denmark-headquartered Novo Nordisk Pharm...
Pharmanovia, a UK-based pharmaceutical company that commercialises novel medicines and revitalises, extends and expands ...
South Korea-based SK bioscience, an innovative vaccine and biotech company, has decided to make an equity investment in ...
Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, con...
South Korea-based Daewoong Pharmaceutical has signed an agreement for license and distribution of potassium-competitive ...
NAVER Corporation has announced a donation of 30 billion KRW over a span of three years to Seoul National University Hos...
GC Biopharma, a South Korean biopharmaceutical company, has announced that its quadrivalent flu vaccine called GC F...
Japan-headquartered Sosei Group Corporation is acquiring from Swiss firm Idorsia Ltd and Idorsia Pharmaceutical Ltd...
The Ministry of Health and Welfare (MoHW) in South Korea has announced the results of the public contest held to sel...
South Korea-based Daewoong Pharmaceutical has obtained approval for a SGLT-2 inhibitor+metformin combination drug in jus...
